Jesus Berdeja, MD
Director of Myeloma Research
25 years treating Myeloma
25 years treating Myeloma
Director of Myeloma Research
Dr. Berdeja joined Sarah Cannon in 2008 and serves as the director of myeloma research. His responsibilities include seeing patients with all types of blood cancers and patients undergoing blood or marrow transplantation. He is the lead investigator in many clinical trials for patients with blood cancers and has published extensively in the subject.
Sarah Cannon Research Institute: Nashville, TN, USA
Subscribe to the weekly "HealthTree Community for Myeloma Newsletter" for Myeloma news, life with Myeloma stories, Myeloma clinical trials, Myeloma 101 articles and events with Myeloma experts.